HAE
Haemonetics Corp.

637
Mkt Cap
$3.05B
Volume
787,198.00
52W High
$87.32
52W Low
$47.32
PE Ratio
18.03
HAE Fundamentals
Price
$64.67
Prev Close
$65.63
Open
$65.50
50D MA
$70.14
Beta
0.66
Avg. Volume
1.04M
EPS (Annual)
$3.31
P/B
3.37
Rev/Employee
$450,156.80
$4,182.21
Loading...
Loading...
News
all
press releases
Haemonetics Corporation $HAE Shares Sold by Fisher Asset Management LLC
Fisher Asset Management LLC trimmed its stake in shares of Haemonetics Corporation (NYSE:HAE - Free Report) by 3.9% in the third quarter, according to its most recent 13F filing with the Securities...
MarketBeat·15h ago
News Placeholder
More News
News Placeholder
William Blair Investment Management LLC Buys 57,332 Shares of Haemonetics Corporation $HAE
William Blair Investment Management LLC boosted its stake in shares of Haemonetics Corporation (NYSE:HAE - Free Report) by 13.7% during the 3rd quarter, according to its most recent 13F filing with...
MarketBeat·1d ago
News Placeholder
Here's Why Haemonetics (HAE) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks·2d ago
News Placeholder
Royce & Associates LP Sells 569,815 Shares of Haemonetics Corporation $HAE
Royce & Associates LP lowered its holdings in Haemonetics Corporation (NYSE:HAE - Free Report) by 44.8% in the third quarter, according to the company in its most recent Form 13F filing with the...
MarketBeat·2d ago
News Placeholder
Vanguard Group Inc. Reduces Stock Position in Haemonetics Corporation $HAE
Vanguard Group Inc. reduced its position in Haemonetics Corporation (NYSE:HAE - Free Report) by 2.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and...
MarketBeat·2d ago
News Placeholder
Ameritas Investment Partners Inc. Has $636,000 Holdings in Haemonetics Corporation $HAE
Ameritas Investment Partners Inc. trimmed its position in shares of Haemonetics Corporation (NYSE:HAE - Free Report) by 99.3% during the 3rd quarter, according to its most recent Form 13F filing with...
MarketBeat·5d ago
News Placeholder
Haemonetics Corporation $HAE Stake Lessened by Citigroup Inc.
Citigroup Inc. decreased its holdings in shares of Haemonetics Corporation (NYSE:HAE - Free Report) by 89.8% during the third quarter, according to its most recent Form 13F filing with the Securities...
MarketBeat·6d ago
News Placeholder
Q1 EPS Estimates for Haemonetics Decreased by Zacks Research
Haemonetics Corporation (NYSE:HAE - Free Report) - Research analysts at Zacks Research dropped their Q1 2027 earnings estimates for shares of Haemonetics in a research report issued on Tuesday...
MarketBeat·6d ago
News Placeholder
Zacks Research Forecasts Increased Earnings for Haemonetics
Haemonetics Corporation (NYSE:HAE - Free Report) - Research analysts at Zacks Research increased their FY2026 EPS estimates for shares of Haemonetics in a research note issued on Tuesday, February...
MarketBeat·7d ago
News Placeholder
Haemonetics Receives FDA Clearance for NexSys PCS Plasma Collection System with Persona PLUS Technology
Haemonetics Receives FDA Clearance for NexSys PCS Plasma Collection System with Persona PLUS Technology Haemonetics Receives FDA Clearance for NexSys PCS Plasma Collection System with Persona PLUS...
PR Newswire·9d ago
<
1
2
...
>

Latest HAE News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.